Experts focus discussion on FDA's role in comparative effectiveness

02/18/2010 | Medical Devices Today

The FDA's role in comparative-effectiveness research was the focus during a meeting called by a task force of the agency's device center. Diana Zuckerman, a patient advocate, suggested the FDA use comparative studies conducted by groups such as the Agency for Healthcare Research and Quality in assessing the efficacy of new and older devices. Timothy Wright, a principal scientist at a New York hospital, said he believes the agency's role is not comparative effectiveness, but public health.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA